Design Therapeutics SG&A Expense (Quarterly) Insights

Design Therapeutics Inc (DSGN)

5.33 -0.09 (-1.66%) USD | NASDAQ | Sep 27, 16:00

5.35 +0.02 (+0.38%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	4.527M
March 31, 2024	4.599M
December 31, 2023	4.109M
September 30, 2023	5.565M
June 30, 2023	5.532M
March 31, 2023	5.921M
December 31, 2022	5.137M
September 30, 2022	4.888M
June 30, 2022	4.344M

Date	Value
March 31, 2022	4.611M
December 31, 2021	3.79M
September 30, 2021	2.798M
June 30, 2021	2.66M
March 31, 2021	1.805M
December 31, 2020	1.186M
September 30, 2020	0.489M
June 30, 2020	0.433M
March 31, 2020	0.388M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.388M

Minimum

Mar 2020

5.921M

Maximum

Mar 2023

3.488M

Average

4.226M

Median

SG&A Expense (Quarterly) Benchmarks